- Core Laboratories (CLB, Financial) maintains its quarterly dividend at $0.01 per share, with a forward yield of 0.33%.
- Analyst consensus suggests a potential price upside of over 39% from current levels.
- GuruFocus estimates indicate a possible 77.88% upside based on the GF Value metric.
Core Laboratories: Dividend Details
Core Laboratories (NYSE: CLB) has confirmed a quarterly dividend payment of $0.01 per share, sustaining its consistent dividend payout history. With this dividend, the company's forward yield stands at 0.33%. Shareholders should note that the dividend is payable on May 27, with the ex-dividend date earmarked for May 5. Investors seeking stable income streams may find this information pertinent as part of their broader portfolio strategy.
Analyst Price Target and Ratings
In terms of valuation, Wall Street analysts have set a one-year price target for Core Laboratories Inc (CLB, Financial) at an average of $16.80. The forecast ranges from a high of $24.00 to a low of $11.00, reflecting diverse perspectives on the stock's potential. The average price target indicates a possible upside of 39.19% from the current trading price of $12.07. Investors can access more in-depth estimates on the Core Laboratories Inc (CLB) Forecast page.
Furthermore, based on evaluations from five brokerage firms, Core Laboratories Inc (CLB, Financial) holds an average recommendation of 3.0, classifying it under a "Hold" status. The rating scale is from 1 to 5, where 1 symbolizes a Strong Buy and 5 represents a Sell. This consensus may guide investors in making informed decisions regarding the stock's potential stability or volatility.
GuruFocus Valuation Insight
According to GuruFocus, the projected GF Value for Core Laboratories Inc (CLB, Financial) is estimated at $21.47 within a year. This implies a significant upside of 77.88% from the current stock price of $12.07. The GF Value is a proprietary metric that evaluates the fair trading value of a stock based on its historical multiples, past growth, and future business projections. Detailed valuation insights are available on the Core Laboratories Inc (CLB) Summary page. Investors are encouraged to consider these metrics when assessing Core Laboratories as a potential investment opportunity.
